Bulletin
Investor Alert

23andMe Holding Co.

NAS: ME

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Feb 3, 2023, 7:32 p.m.

ME
/zigman2/quotes/222659849/composite

$

2.73

Change

+0.04 +1.49%

Volume

Volume 38,490

Quotes are delayed by 20 min

/zigman2/quotes/222659849/composite

Previous close

$ 2.75

$ 2.69

Change

-0.06 -2.18%

Day low

Day high

$2.64

$2.80

Open

52 week low

52 week high

$2.02

$6.31

Open

Insider Actions for 23andMe Holding Co.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
12/05/2022 Kathy L. Hibbs
Chief Administrative Officer
26,259   Disposition at $3.25 per share. 85,341
11/20/2022 Joseph Selsavage
Interim CFO
10,105   Derivative/Non-derivative trans. at $2.99 per share. 30,213
11/20/2022 Kathy L. Hibbs
Chief Administrative Officer
4,628   Derivative/Non-derivative trans. at $2.99 per share. 13,837
11/20/2022 Kenneth J. Hillan
Chief Therapeutics Officer
4,628   Derivative/Non-derivative trans. at $2.99 per share. 13,837
11/11/2022 Richard H. Scheller
Director
18,421   Disposition at $3.24 per share. 59,684
09/06/2022 Valerie C. Montgomery Rice
Director
3,577   Award at $3.08 per share. 11,017
09/06/2022 Valerie C. Montgomery Rice
Director
14,633   Award at $0 per share. 0
09/06/2022 Sandra Rae Hernández
Director
3,251   Award at $3.08 per share. 10,013
09/06/2022 Sandra Rae Hernández
Director
14,633   Award at $0 per share. 0
09/06/2022 Peter J. Taylor
Director
14,633   Award at $0 per share. 0
09/06/2022 Patrick Shuao-Fong Chung
Director
3,414   Award at $3.08 per share. 10,515
09/06/2022 Patrick Shuao-Fong Chung
Director
14,633   Award at $0 per share. 0
09/06/2022 Roelof Frederik Botha
Director
3,251   Award at $3.08 per share. 10,013
09/06/2022 Roelof Frederik Botha
Director
14,633   Award at $0 per share. 0
09/06/2022 Neal Mohan
Director
14,633   Award at $0 per share. 0
09/06/2022 Richard H. Scheller
Director
14,633   Award at $0 per share. 0
09/01/2022 Joseph Selsavage
Interim CFO
129,761   Award at $0 per share. 0
08/25/2022 Valerie C. Montgomery Rice
Director
17,821   Award at $3.03 per share. 53,997
08/25/2022 Valerie C. Montgomery Rice
Director
57,755   Award at $0 per share. 0
08/25/2022 Sandra Rae Hernández
Director
13,201   Award at $3.03 per share. 39,999
08/25/2022 Sandra Rae Hernández
Director
57,755   Award at $0 per share. 0
08/25/2022 Peter J. Taylor
Director
57,755   Award at $0 per share. 0
08/25/2022 Patrick Shuao-Fong Chung
Director
18,811   Award at $3.03 per share. 56,997
08/25/2022 Patrick Shuao-Fong Chung
Director
57,755   Award at $0 per share. 0
08/25/2022 Roelof Frederik Botha
Director
16,501   Award at $3.03 per share. 49,998
08/25/2022 Roelof Frederik Botha
Director
57,755   Award at $0 per share. 0
08/25/2022 Neal Mohan
Director
57,755   Award at $0 per share. 0
08/25/2022 Richard H. Scheller
Director
57,755   Award at $0 per share. 0
08/24/2022 Kenneth J. Hillan
Chief Therapeutics Officer
8,753   Disposition at $3.64 per share. 31,860
08/20/2022 Kathy L. Hibbs
Chief Administrative Officer
4,628   Derivative/Non-derivative trans. at $3.33 per share. 15,411
08/20/2022 Steven J. Schoch
Chief Financial Officer
4,782   Derivative/Non-derivative trans. at $3.33 per share. 15,924
08/20/2022 Kenneth J. Hillan
Chief Therapeutics Officer
4,628   Derivative/Non-derivative trans. at $3.33 per share. 15,411
06/01/2022 Kathy L. Hibbs
Chief Administrative Officer
4,627   Derivative/Non-derivative trans. at $2.82 per share. 13,048
06/01/2022 Steven J. Schoch
Chief Financial Officer
4,782   Derivative/Non-derivative trans. at $2.82 per share. 13,485
06/01/2022 Kenneth J. Hillan
Chief Therapeutics Officer
4,627   Derivative/Non-derivative trans. at $2.82 per share. 13,048
03/10/2022 Evan M. Lovell
Director
11,467   Acquisition at $4.41 per share. 50,569

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
5 Sales
0
64,041
Last 6 months
23 Purchases
9 Sales
716,304
86,832
Last 12 months
31 Purchases
12 Sales
1,930,248
100,868

Officers and Executives

Ms. Anne E. Wojcicki
President, Chief Executive Officer & Director
Mr. Joseph Selsavage
Chief Financial & Accounting Officer
Mr. Steve Lemon
Vice President-Engineering
Dr. Joyce Tung
Vice President-Research
Dr. L. Okey Onyejekwe
VP-Healthcare Operations & Medical Affairs
Dr. Joseph R. Arron
Chief Scientific Officer
Ms. Kathy L. Hibbs
Secretary & Chief Administrative Officer
Dr. Kenneth J. Hillan
Chief Therapeutics Officer
Mr. Adam Auton
Vice President-Human Genetics
Mr. David Baker
Chief Security Officer
Dr. Arnab Chowdry
Vice President-Genetic Technology
Mr. Kent Hillyer
Vice President-Customer Care
Dr. Jennifer Low
Head-Therapeutics Development
Mr. Mike Polcari
Vice President & Chief Architect
Dr. William Richards
Vice President-Drug Discovery
Dr. Monica Viziano
VP-Portfolio Strategy & Alliance Management
Mr. Paul Johnson
Chief Operating Officer-Consumer
Mr. Daniel Chu
Chief Product Officer
Mr. Evan M. Lovell
Director
Dr. Richard H. Scheller
Director
Ms. Tracy Keim
Vice President-Consumer Marketing & Brand
Dr. D. Wade Walke
Vice President-Investor Relations
Ms. Jacquie Cooke Haggarty
General Counsel & Privacy Officer
Mr. Roelof Frederik Botha
Independent Director
Mr. Patrick Shuao-Fong Chung
Independent Director
Mr. Peter J. Taylor
Independent Director
Dr. Valerie C. Montgomery Rice
Independent Director
Dr. Sandra Rae Hernández
Independent Director
Mr. Neal Mohan
Independent Director
Link to MarketWatch's Slice.